Abdominal acupuncture for treatment of allergic rhinitis:A randomized controlled clinical trial
10.3969/j.issn.1673-9701.2024.22.009
- VernacularTitle:腹针治疗过敏性鼻炎的随机对照临床试验
- Author:
Zhaoxin LI
1
;
Qian LIU
;
Rongyuan ZHANG
;
Xuefei REN
;
Jianfeng TU
;
Jiaping WU
;
Dongmei WANG
;
Caifeng GUO
Author Information
1. 北京中医药大学房山医院针灸科,北京 102400
- Keywords:
Abdominal acupuncture;
Allergic rhinitis;
Rhinoconjunctivitis quality of life questionnaire
- From:
China Modern Doctor
2024;62(22):37-40,49
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effect of abdominal acupuncture in treating allergic rhinitis(AR).Methods Twenty-seven AR patients who attended Fangshan Hospital,Beijing University of Chinese Medicine from August to October 2022 were selected.They were divided into treatment group(15 cases)and control group(12 cases)according to randomized numerical table method.The treatment group received abdominal acupuncture.The control group at the same point was used one-time sterile cannula acupuncture to simulate acupuncture,but no needle was inserted into the acupoint.Two groups were treated,3 times a week for 4 weeks.The visual analogue scale(VAS),rhinoconjunctivitis quality of life questionnaire(RQLQ),Pittsburgh sleep quality index(PSQI)scores,and the histamine(HIS),leukotriene D4(LTD4),immunoglobulin E(IgE)levels were compared between two groups before and after treatment.Results At each time point after treatment,the VAS,RQLQ,PSQI scores and HIS,LTD4,IgE levels of patients in treatment group were significantly lower than those before treatment(P<0.05).There were no statistically significant differences in VAS,RQLQ,and PSQI scores,the HIS,LTD4,and IgE levels after 2-week treatment in both groups(P>0.05).After 4-week treatment and follow-up 4-week,the VAS,RQLQ,and PSQI scores,the HIS,and LTD4 levels in treatment group were significantly lower than those in control group(P<0.05).Conclusion Abdominal acupuncture has good therapeutic effect on AR and significantly improves life quality of the patients,which can reduce the levels of HIS,LTD4 and IgE.The therapy is worthy of clinical application.
